ARCHIVES

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Director Declines To Fund P-4 Breast Cancer Chemoprevention Trial.

June 22, 2007

Dendritic Cell Vaccine May Boost Median Survival

March 25, 2011

RFA For Patterns Of Care Study in Elderly Issues

January 14, 1983

Komen Board Approved Defunding Planned Parenthood, Says Karen Handel

February 10, 2012

Oncology Faces Cuts In CMS Revamp Of Physician Payments Under Part B.

July 10, 2009

In Brief: O’Conor Now Top Prospect If Rauscher Leaves; Flood Gives NCI Increase Of Only $11 Million

May 14, 1976